As reported previously, CUL4B activates Wnt/β‐catenin signaling by stabilizing β‐catenin in response to GSK3‐mediated degradation in hepatocellular carcinomas.[74] Despite this, the mechanism behind these phenotypes requires further investigation. This evidence concerns the gene CUL4B and hepatocellular carcinoma.